K. Brown

Natl Jewish Hlth

Poster Author Of 2 e-Posters

 ePosters
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A4597 - Rationale, Design and Objectives of Two Phase III, Randomised, Placebo-Controlled Studies of GLPG1690, a Novel Autotaxin Inhibitor, in Idiopathic Pulmonary Fibrosis (ISABELA 1 and 2)

Presenter:
Date
05/21/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
C34 - ILD AND IPF: CLINICAL AND MECHANISTIC STUDIES
Session Type
Thematic Poster Session
Authors
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A5627 - Characteristics of Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) in the INBUILD Trial of Nintedanib

Presenter:
Date
05/21/2019
Room
Room C140/C142 (Level 1), KBHCCD
Session Name
C101 - NON-IDIOPATHIC INTERSTITIAL PNEUMONIA NATURAL HISTORY AND PROGNOSIS AND ILD THERAPY
Session Type
Poster Discussion Session
Authors